• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Renoprotective effect of pentoxifylline in advanced chronic kidney disease.

作者信息

Kao Chih-Chin, Wu Mai-Szu

机构信息

Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.

Division of Nephrology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan; Department of Internal Medicine, School of Medicine, Taipei Medical University, Taipei 110, Taiwan.

出版信息

J Formos Med Assoc. 2015 Jan;114(1):94. doi: 10.1016/j.jfma.2014.05.005. Epub 2014 Jun 26.

DOI:10.1016/j.jfma.2014.05.005
PMID:24974130
Abstract
摘要

相似文献

1
Renoprotective effect of pentoxifylline in advanced chronic kidney disease.己酮可可碱对晚期慢性肾脏病的肾脏保护作用
J Formos Med Assoc. 2015 Jan;114(1):94. doi: 10.1016/j.jfma.2014.05.005. Epub 2014 Jun 26.
2
Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease.己酮可可碱联合血管紧张素转换酶抑制剂或血管紧张素 II 受体阻滞剂在晚期慢性肾脏病中的肾脏保护作用
J Formos Med Assoc. 2014 Apr;113(4):219-26. doi: 10.1016/j.jfma.2014.01.002. Epub 2014 Feb 7.
3
Reply to comment on "Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease".对“己酮可可碱联合血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂在晚期慢性肾病中的肾脏保护作用”评论的回复
J Formos Med Assoc. 2015 Jan;114(1):95-6. doi: 10.1016/j.jfma.2014.05.003. Epub 2014 Jun 18.
4
Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis.己酮可可碱联合血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体拮抗剂治疗慢性肾脏病蛋白尿及肾功能的荟萃分析
J Int Med Res. 2017 Apr;45(2):383-398. doi: 10.1177/0300060516663094. Epub 2017 Jan 1.
5
Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.己酮可可碱对慢性肾脏病患者肾小球滤过率下降的影响：一项前瞻性、双盲、随机、安慰剂对照试验。
Am J Kidney Dis. 2009 Apr;53(4):606-16. doi: 10.1053/j.ajkd.2008.11.026. Epub 2009 Feb 12.
6
Can Pentoxifylline be used as Adjunct Therapy to ACE Inhibitors and ARBs in Preserving Kidney Function?己酮可可碱能否作为辅助治疗药物与血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂联合使用以保护肾功能？
J Pharm Pharm Sci. 2016;19(1):1-7. doi: 10.18433/J3K020.
7
The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.己酮可可碱对糖尿病肾病蛋白尿的影响：一项荟萃分析。
Am J Kidney Dis. 2008 Sep;52(3):454-63. doi: 10.1053/j.ajkd.2008.01.025. Epub 2008 Apr 22.
8
Effect of pentoxifylline in proteinuric chronic kidney disease: a systematic review and meta-analysis.己酮可可碱在蛋白尿性慢性肾脏病中的作用：一项系统评价和荟萃分析。
J Nephrol. 2016 Oct;29(5):653-62. doi: 10.1007/s40620-015-0240-y. Epub 2015 Oct 28.
9
Effects of suspending ACE inhibitors and ARBs in advanced chronic kidney disease.在晚期慢性肾病中停用血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂的影响。
Nefrologia. 2012 May 14;32(3):400-1. doi: 10.3265/Nefrologia.pre2012.Mar.11422.
10
Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?对于使用最大剂量血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂均无效的糖尿病肾小球硬化症患者，加用己酮可可碱会降低蛋白尿吗？
J Nephrol. 2007 Jul-Aug;20(4):410-6.